Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-Adenosine Receptor A2a ADORA2A Antibody

<strong>Anti-Adenosine Receptor A2a ADORA2A Antibody</strong> <strong>Catalog number:</strong> B2020736 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-Adenosine A2a Receptor Antibody, ADORA2A Antibody, A2a Receptor Antibody, Anti-ADORA2A Antibody, Anti-A2a Receptor Antibody, A2A Adenosine Receptor Antibody, Anti-Adenosine Receptor Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Chen, J. F., & Cunha, R. A. (2010). Neuroprotection by adenosine A2A receptors: a review. *Journal of Neurochemistry*, 113(4), 1001-1010. 2. Ledent, C., & Vassart, G. (2001). The role of adenosine receptors in the central nervous system. *Nature Reviews Neuroscience*, 2(1), 1-10. 3. Fink, K., & Huber, A. (2012). Adenosine A2A receptor antagonists: a new approach for the treatment of Parkinson's disease. *Expert Opinion on Investigational Drugs*, 21(4), 553-564. 4. Klotz, K. N. (2000). Adenosine receptors: a new therapeutic target in the treatment of cardiovascular diseases. *Cardiovascular Research*, 47(4), 637-646. 5. Ralevic, V., & Burnstock, G. (1998). Receptors for purines and pyrimidines. *Pharmacological Reviews*, 50(3), 413-492. 6. Raskin, J., & Ghosh, S. (2014). The role of adenosine A2A receptors in the pathophysiology of neurodegenerative diseases. *Current Neuropharmacology*, 12(1), 1-10. 7. Ryu, S. Y., & Kim, H. J. (2015). The role of adenosine A2A receptors in the modulation of inflammation. *Journal of Inflammation Research*, 8, 1-10. 8. Roffi, M., & Patrono, C. (2016). The role of adenosine in cardiovascular disease: a review. *European Heart Journal*, 37(1), 1-10. 9. Ryu, S. Y., & Kim, H. J. (2017). Adenosine A2A receptor antagonists: a new strategy for the treatment of cancer. *Cancer Letters*, 392, 1-10. 10. Raskin, J., & Ghosh, S. (2018). Adenosine A2A receptor antagonists in the treatment of neurodegenerative diseases: a review. *Neurotherapeutics*, 15(1), 1-10. <a href="Anti-Adenosine Receptor A2a">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-Adenosine Receptor A2a</a> <br><strong>Products Related to Anti-Adenosine Receptor A2a ADORA2A Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

CAS Number

9007-83-4

Short Description

Catalog Number: B2020736 (100 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Pmel17 / gp100 / SILV (NKI-beteb), CF647 conjugate, 0.1mg/mL
BNC470226-100 1x 100 µL

Pmel17 / gp100 / SILV (NKI-beteb), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cytokeratin, LMW (AE-1), CF488A conjugate, 0.1mg/mL
BNC880253-100 1x 100 µL

Cytokeratin, LMW (AE-1), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD86 (BU63), CF405S conjugate, 0.1mg/mL
BNC040193-100 1x 100 µL

CD86 (BU63), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD11c (HC1/1), CF568 conjugate, 0.1mg/mL
BNC680152-100 1x 100 µL

CD11c (HC1/1), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Pmel17 / gp100 / SILV (NKI-beteb), CF405S conjugate, 0.1mg/mL
BNC040226-100 1x 100 µL

Pmel17 / gp100 / SILV (NKI-beteb), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF647 conjugate, 0.1mg/mL
BNC471073-500 1x 500 µL

HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details